一项初步研究介绍了使用电子患者报告结果 (ePRO) 的Bring Your Own Device (BYOD) 在日本市场营销后监测中
Naomi Sugimoto1, Mika Morimasa2, Hidetoshi Misawa3
1PMS Affairs, Pfizer R&D Japan, Shinjuku Bunka Quint Bldg. 3-22-7, Yoyogi, Shibuya-ku, Tokyo, 151-8589, Japan. naomi.sugimoto@pfizer.com.
Therapeutic innovation & regulatory science
|September 24, 2025
概括
电子患者报告结果 (ePRO) 使用自带设备 (BYOD) 在试点研究中实现了与纸质方法相比的数据完整性. 这种方法对于营销后监测是可行的,尽管建议改进系统.
科学领域:
- 临床研究方法论临床研究方法论
- 医疗信息学 医疗信息学
背景情况:
- 通过自己的设备 (BYOD) 采用电子患者报告结果 (ePRO) 数据收集在临床试验中越来越多.
- 进行了初步评估,以评估ePRO在日本使用BYOD进行监管要求的市场监测 (PMS).
研究的目的:
- 评估在日本使用BYOD实施ePRO的流程和可行性,用于营销后监测.
- 将 ePRO 的数据完整性和可用性与传统的基于纸张的 PRO 方法进行比较.
主要方法:
- 进行了一项多中心,两期,两序,交叉的观测研究.
- 参与者被分为两组,一组开始使用ePRO,另一组使用纸质PRO,每组为期七天.
- 用户可用性,实施,支持和ePRO的材料通过问卷进行了评估.
主要成果:
- 使用ePRO收集数据与纸质PRO可比,基于性别或年龄相关的缺失数据趋势,数据输入状态没有显著差异.
- 超过一半的参与者对ePRO系统问卷进行了积极回应.
- 调查人员发现ePRO系统材料有用,但确定了需要改进的领域.
结论:
- 在为期两周的试点项目中,ePRO在积极的临床环境中展示了与纸质方法相比的数据完整性.
- 确定了在实际PMS中实施ePRO的关键考虑因素.
- 建议对符合当地法规的研究进行进一步评估.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Bioavailability Study Design: Healthy Subjects Versus Patients
144
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
144
Pulse rhythm
1.3K
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.3K
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Holter Monitor: 24-Hour Monitoring
2.1K
Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
2.1K


